SpecialtyCare is honored to share that our abstract entitled: “Experience with 46 patients with COVID-19 and Severe Pulmonary Compromise treated with Extracorporeal Membrane Oxygenation,” has been selected for the opening presentation of the first scientific session at The Southern Thoracic Association’s (STSA) 67th annual meeting. The meeting is scheduled for November 4-7, 2020 in Orlando, FL.

This abstract and presentation follow our previous publication in the American Society for Artificial Internal Organs Journal entitled: “Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in COVID-19: Experience with 32 patients.” As the pandemic evolves, SpecialtyCare continues to place an important focus on sharing our work with the industry, including a summary of the first 100 patients with COVID-19 treated with ECMO. Our hope is that by sharing our early experience regarding how our surgical partners and perfusionists around the country are managing ECMO in patients with coronavirus, we will enhance decision-making at the bedside.

To learn more about our COVID-19 and ECMO research initiatives, view previous webinar presentation discussions, and see upcoming presentation dates, check out the SpecialtyCare blog.